Breast Implants and Desmoid Tumors: Is There a Link?
"A closer look at the research surrounding breast implants and the development of desmoid tumors, a rare connective tissue growth."
Desmoid tumors are rare growths that develop in the connective tissues of the body. While they aren't cancerous in the traditional sense—they don't spread to distant organs—they can be locally aggressive, infiltrating surrounding tissues. When these tumors occur in the breast, they're referred to as breast desmoid tumors (BDT), a particularly uncommon presentation.
Recently, some researchers have explored a possible connection between breast implants and the development of BDT. The theory suggests that the fibrous capsule that forms around the implant could, in some way, contribute to the formation of these tumors. But is this connection real, or simply a coincidence?
This article dives into a research review investigating the potential correlation between BDT and breast implant surgery. We'll explore the findings, incidence rates, and what this means for individuals with or considering breast implants.
What the Evidence Shows
Breast desmoid tumors are rare benign breast growths that can present like malignancy, and current guidance is based on limited evidence from case reports and small case series. A 2021 single-center study identified patients with breast desmoid tumors and breast implants from radiology, breast, and sarcoma databases covering 2000–2021, then calculated a standardized incidence ratio to assess a possible association. The supplied study summary does not report the SIR result, so it does not establish the size or direction of any association. One reported reconstruction case was initially thought to be recurrent breast cancer; imaging was obscured by the implant, and excision found a positive deep margin that required rib resection, synthetic mesh, and pectoralis major flap reconstruction.
A Rare Tumor in Implant Reconstruction
A 2023 case report describes a desmoid tumor detected after mastectomy with implant-based reconstruction in a patient with a history of left-breast intraductal carcinoma. Desmoid tumors are described as rare, locally aggressive tumors that are usually abdominally based; the report states they account for 0.2% of breast tumors. Prior surgery, familial adenomatous polyposis, pregnancy, and high-estrogen states are identified as factors associated with chest-wall desmoid tumor occurrence. The case report describes the tumor being mistaken for recurrent breast cancer during workup, with implant-obscured imaging and excision revealing a positive deep margin.
What Does the Research Say About Breast Implants and Desmoid Tumors?
A comprehensive literature review was conducted, examining reported cases of BDT in individuals with breast implants. The search focused on identifying any potential patterns or associations between the two.
- The average time between getting breast implants and diagnosis of BDT was approximately 2.96 years.
- A mix of silicone and saline implants were represented in the cases.
- The most common symptom was a palpable mass in the breast.
Recent Reviews and Related Reports
A 2024 review searched Medline and Embase for published cases of breast desmoid tumors since 2000, descriptively analyzing clinical presentation, diagnosis, treatment, and outcomes. The supplied summary does not provide the review’s findings or outcome figures. Separate sources mention breast seroma and desmoid tumors among conditions suggested to be associated with silicone breast implants, but do not establish causation. The pregnancy case-report sources concern a 29-year-old woman with a large anterior abdominal-wall desmoid tumor, rather than a breast tumor.
Local Aggression and Recurrence
A 2017 article describes desmoid tumors as borderline connective-tissue tumors arising in musculo-aponeurotic stromal elements. They can grow infiltratively and aggressively at the local site, while usually not metastasizing. The article also reports high recurrence and complication rates. Breast desmoid tumors are characterized as a rare extra-abdominal form.
The Verdict: A Need for More Data
While this research review offers valuable insights, it's important to acknowledge its limitations. Detailed clinical information was lacking in many of the reviewed cases, and there's a possibility of underreporting or inaccurate reporting, especially considering that many breast operations are performed in private practice settings.
Treatment Direction and Open Questions
A 2026 discussion by Mark Agulnik, MD, describes a shift away from surgery and toward targeted treatment for progressive desmoid tumors. It identifies treatment sequencing as a major next question. Another 2026 source says clinicians assess treatment success beyond scan shrinkage, considering symptoms, stable disease, and surveillance insights from desmoid-tumor trials. These summaries point to ongoing questions about how to select and evaluate treatment; they do not provide specific trial results.
The researchers call for the creation of a world registry to accurately document all cases of BDT associated with breast implant surgery. This registry would involve contributions from plastic surgeons, healthcare providers, and silicone implant manufacturers, providing a more comprehensive dataset for analysis.
For now, the potential association between breast implants and desmoid tumors remains unconfirmed. Further research and data collection are needed to fully understand if there's a connection, and if so, what factors might contribute to it.